Skip to main content
Equibles
OGN logo

OGN · Organon & Co. · Metrics

Track OGN — free

Use OGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$13.71 +0.01 (+0.07%) At close · Oct 1
S&P 600 member Russell 1000 member Rebalance outlook locked
Going-concern doubt — cleared Jul 31, 2026

The latest filing no longer states the doubt (first flagged May 4, 2026).

View the 10-Q filed Jul 31, 2026
Market Cap
$3.61B
Shares
262.61M
Volume · Oct 1 2.1M Avg daily vol (3M) 2.7M

OGN metrics

84 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.71
Market cap
$3.61B

Price action

20 metrics
Price change (1W)
-0.2%
Price change (30D)
-0.4%
Price change (3M)
+1.3%
Price change (6M)
+123.1%
Price change (YTD)
+91.1%
Price change (1Y)
+28.3%
Trailing year
Price change (5Y)
-58.2%
52-week high
$13.78
52-week low
$5.70
Change from 52-week high
-0.6%
Change from 52-week low
+140.4%
Annualized volatility
65.7%
Annualized volatility (3M)
2.9%
Beta
0.6
RSI (14D)
50.7
Price vs SMA 50
+0.2%
Price vs SMA 200
+26.6%
Avg volume (3M)
2.71M
Relative volume
0.8
Average dollar volume
$36.98M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
262.61M

Valuation

12 metrics
P / E (TTM)
17.6
Trailing earnings · reciprocal yield 5.7%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 55.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 169.9%
P / book
3.6
reciprocal yield 27.9%
FCF yield
15.7%
TTM · current market cap
Buyback yield
—
P / FCF
6.4
reciprocal yield 15.7%
P / operating cash flow
4.9
reciprocal yield 20.4%
Earnings yield
5.8%

Historical valuation

8 metrics
P / E historical average (3Y)
6.9×
reciprocal yield 14.6%
P / E historical average (5Y)
6.9×
reciprocal yield 14.5%
EV / revenue historical average (3Y)
1.9×
reciprocal yield 53.3%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 48.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
8.6%
Shareholder yield
0.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-04-30

Profitability

9 metrics
Gross margin
52.7%
Operating margin
—
Trailing 12 months
Net margin
3.4%
Gross profit (TTM)
$3.23B
Operating profit (TTM)
—
Net income (TTM)
$209.00M
Trailing 12 months
Diluted EPS (TTM)
$0.78
FCF margin
9.3%
Effective tax rate
57.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.89

Growth

11 metrics
Revenue growth YoY
-2.3%
Year over year
Net income growth YoY
-25.5%
Revenue (TTM)
$6.13B
Trailing 12 months
EPS growth YoY
-28.6%
Shares change YoY
+4.0%
Year over year · more shares
Revenue CAGR (3Y)
+0.2%
Revenue CAGR (5Y)
-1.0%
EPS CAGR (3Y)
-41.5%
EPS CAGR (5Y)
-39.0%
FCF CAGR (3Y)
-6.7%
FCF CAGR (5Y)
-23.3%

Quality

14 metrics
Return on equity
20.8%
Return on assets
1.6%
Debt / equity
8.5
Current ratio
2.0
EBITDA (TTM)
—
Free cash flow (TTM)
$567.00M
Quick ratio
1.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$7.42B
Latest balance sheet
Cash & equivalents
$1.13B
Total assets
$13.18B
Total debt
$8.55B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$737.00M
Capital expenditures (TTM)
$170.00M
R&D (TTM)
$358.00M
SG&A (TTM)
$1.71B
Stock compensation (TTM)
$75.00M
R&D / revenue
5.8%
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
646
13F filer change QoQ
+30
Institutional ownership
86.5%

Short interest

3 metrics
Short interest
6.7%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$200,307
Insider-sentiment score
49 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1821825 CUSIP 68622V106 13F (30d) 22 filings 14 filers Visit website Investor relations